To Evaluate the Efficacy and Safety of ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defects Caused by Neurotrophic Keratitis

NCT07120308 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Corneal Epithelial Defect

Interventions

DRUG: ZKY001 eye drops
DRUG: Vehicle (placebo)

Sponsor

Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.